CD49fhigh Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fukamachi, Hiroshi ^a   Seol, Hyang Sook ^b   Shimada, Shu ^a   Funasaka, Chikako ^a   Baba, Kanako ^a   Kim, Ji Hun ^b   Park, Young Soo ^b   Kim, Mi Jeung ^b   Kato, Keiji ^a   Inokuchi, Mikito ^a   Kawachi, Hiroshi ^a   Yook, Jeong Hwan ^b   Eishi, Yoshinobu ^a   Kojima, Kazuyuki ^a   Kim, Woo Ho ^c   Jang, Se Jin ^b   Yuasa, Yasuhito ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; CELL MARKER; DOXIFLURIDINE; DOXORUBICIN; FLUOROURACIL; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CANCER SURGERY; CARCINOGENESIS; CARCINOGENICITY; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL STRUCTURE; CELLULAR PARAMETERS; CELLULAR SPHERE FORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GASTRIC TUMOR INITIATING CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULARLY TARGETED THERAPY; PRIMARY CULTURE; PROTEIN SUBUNIT; STOMACH CANCER; STOMACH TUMOR; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FLOXURIDINE; FLUOROURACIL; HUMANS; INHIBITORY CONCENTRATION 50; INTEGRIN ALPHA6; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84883155193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072438     Document Type: Article

References (53)

1. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907.
2. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions. Cancer Res 66: 9339-9344.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
5. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
6. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445: 106-110.
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
8. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037.
9. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104: 973-978.
10. Yang W, Yan HX, Chen L, Liu Q, He YQ, et al. (2008) Wnt/β-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 68: 4287-4295.
11. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, et al. (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020.
12. Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ, et al. (2011) Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell Mol Life Sci 68: 3589-3605.
13. Chen T, Yang K, Yu J, Meng W, Yuan D, et al. (2012) Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res 22: 248-258.
14. Zhang C, Li C, He F, Cai Y, Yang H, (2011) Identification of CD44+CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol 137: 1679-1686.
15. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, et al. (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc- and thereby promotes tumor growth. Cancer Cell 19: 387-400.
16. da Cunha CB, Oliveira C, Wen X, Gomes B, Sousa S, et al. (2010) De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest 90: 1604-1614.
17. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, et al. (2009) Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69: 8555-8562.
18. Meyer MJ, Fleming JM, Lin AF, Hussnain SA, Ginsburg E, et al. (2010) CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Res 70: 4624-4633.
19. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, et al. (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432.
20. Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, et al. (2013) CD49f-positive cell population efficiently enriches colon cancer-initiating cells. Int J Oncol 43: 425-430.
21. Pastrana E, Silva-Vargas V, Doetsch F, (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8: 486-498.
22. Fukamachi H, Ichinose M, Tsukada S, Kurokawa K, Shiokawa K, et al. (1995) Growth of fetal rat gastro-intestinal epithelial cells is region-specifically controlled by growth factors and substrata in primary culture. Develop Growth Differ 37: 11-19.
23. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, et al. (2010) Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6: 25-36.
24. Fukamachi H, (1992) Proliferation and differentiation of fetal rat intestinal epithelial cells in primary serum-free culture. J Cell Sci 103: 511-519.
25. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
26. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, et al. (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106: 16281-16286.
27. Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, et al. (2012) CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. J Cell Physiol 227: 2686-2693.
28. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.
29. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
30. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
31. Eyler CE, Rich JN, (2008) Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 26: 2839-2845.
32. Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, et al. (2011) Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Oncogene 31: 671-682.
33. Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, et al. (2012) Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumorigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. J Pathol 228: 391-404.
34. Aumailley M, Timpl R, Sonnenberg A, (1990) Antibody to integrin α6 subunit specifically inhibits cell-binding to laminin fragment 8. Exp Cell Res 188: 55-60.
35. Belkin AM, Stepp MA, (2000) Integrins as receptors for laminins. Microsc Res Tech 51: 280-301.
36. Guo W, Giancotti FG, (2004) Integrin signalling during tumour progression. Nature Rev Mol Cell Bio 5: 816-826.
37. Yoon SO, Shin S, Lipscomb EA, (2006) A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the α6β4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. Cancer Res 66: 2732-2739.
38. Yamamoto H, Masters JR, Dasgupta P, Chandra A, Popert R, et al. (2012) CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate. PLoS One 7: e46979.
39. Lu P, Weaver VM, Werb Z, (2012) The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol 196: 395-406.
40. Jun S, Thompson E, Gottardis M, Torri J, Yamamura K, et al. (1994) Laminin adhesion-selected primary human colon-cancer cells are more tumorigenic than the parenteral and nonadherent cells. Int J Oncol 4: 55-60.
41. Kim WH, Lee BL, Kim DK, Kleinman HK, (1999) Laminin-1-adherent cancer cells show increased proliferation and decreased apoptosis in vivo. Anticancer Res 9: 3067-3071.
42. Weinel RJ, Rosendahl A, Pinschmidt E, Kisker O, Simon B, et al. (1995) The α6-integrin receptor in pancreatic carcinoma. Gastroenterology 108: 523-532.
43. Tani T, Karttunen T, Kiviluoto T, Kivilaakso E, Burgeson RE, et al. (1996) α6β4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Am J Pathol 149: 781-793.
44. Koike N, Todoroki T, Komano H, Shimokama T, Ban S, et al. (1997) Invasive potentials of gastric carcinoma cell lines: role of α2 and α6 integrins in invasion. J Cancer Res Clin Oncol 123: 310-316.
45. Yu KR, Yang SR, Jung JW, Kim H, Ko K, et al. (2012) CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 30: 876-887.
46. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, et al. (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8: 323-335.
47. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
48. Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, et al. (2011) Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology 152: 2150-2163.
49. Rodin S, Domogatskaya A, Ström S, Hansson EM, Chien KR, et al. (2010) Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 28: 611-615.
50. Ichinose M, Yahagi N, Matsubara Y, Tsukada S, Oka M, et al. (1997) Substratum-dependent and region-specific attachment and proliferation of gastrointestinal epithelial cells in primary serum-free culture. Biochem Biophys Res Commun 230: 537-541.
51. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659.
52. Sachlos E, Risueño RM, Laronde S, Shapovalova Z, Lee JH, et al. (2012) Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 149: 1284-1297.
53. Adikrisna R, Tanaka S, Muramatsu S, Aihara A, Ban D, et al. (2012) Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology 143: 234-245.